Startseite>>Signaling Pathways>> Immunology/Inflammation>> CD73>>CD73-IN-1

CD73-IN-1

Katalog-Nr.GC31914

CD73-IN-1 ist ein Inhibitor von CD73, der bei der Behandlung von Krebs verwendet werden kann, extrahiert aus dem Patent WO 2017153952 A1, Beispiel 80.

Products are for research use only. Not for human use. We do not sell to patients.

CD73-IN-1 Chemische Struktur

Cas No.: 2132396-40-6

Größe Preis Lagerbestand Menge
10mM (in 1mL DMSO)
248,00 $
Auf Lager
1mg
101,00 $
Auf Lager
5mg
304,00 $
Auf Lager
10mg
459,00 $
Auf Lager
25mg
920,00 $
Auf Lager
50mg
1.379,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

CD73-IN-1 is an inhibitor of CD73 which can be used in the treatment of cancer extracted from patent WO 2017153952 A1, example 80.

[1]. Jerry Leroy Adams, et al. 5-sulfamoyl-2-hydroxybenzamide derivatives. WO 2017153952 A1.

Bewertungen

Review for CD73-IN-1

Average Rating: 5 ★★★★★ (Based on Reviews and 39 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for CD73-IN-1

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.